Last updated: 2026-09-06 05:39:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
CeriBell, Inc. (CBLL) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $24.72, with a market capitalisation of $952.16M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.85 to $25.67. This page covers its latest market performance, valuation, price trends and company information.
$952.16M | |
$24.57 | |
$32.75 | |
$10.01 | |
$24.57 | |
182.56K | |
-- | |
-- | |
$25.67 | |
$10.85 | |
-- | |
-- |
CeriBell, Inc. (CBLL) last closed at $24.57 as of 2026-09-04 23:31:00, unchanged from the previous close of $24.57.
During the latest regular trading session, CBLL traded between $10.01 and $32.75, with a volume of 182.56K shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, CeriBell, Inc. (CBLL) moved from $23.66 to $24.72, representing a gain of 4.48% ($1.06).
The stock traded between $24.26 and $25.67 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 296.22 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 93.6%
CBLL is currently trading at $24.72, placing it 93.6% of the way from its 52-week low of $10.85 to its 52-week high of $25.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 300 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CeriBell, Inc. (CBLL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.